Prevalence of thyroid eye disease in Graves’ disease: A meta‐analysis and systematic review
Clinical Endocrinology, 2020 Thyroid eye disease (TED) is a debilitating condition that frequently manifests in patients suffering from Graves’ disease (GD). This study aims to analyse the prevalence of TED among GD patients, with a focus on geographical region‐specific rates.
Y. Chin +7 more
semanticscholar +1 more source
Graves\u27 Disease and Major Histocompatibility Complex Class II: A Meta-Analysis of HLA-DQ and HLA-DRB1 [PDF]
, 2023 Background: Human leukocyte antigen (HLA) class II has shown potential in determining prognosis, understanding medication reactions, and predicting onset of Graves’ disease.
Hussein, Mohamed +3 more
core +2 more sources
Convolutional module for heart localization and segmentation in MRI [PDF]
ICIAP 2022, Part I, LNCS 13231, 2021 Magnetic resonance imaging (MRI) is a widely known medical imaging technique used to assess the heart function. Deep learning (DL) models perform several tasks in cardiac MRI (CMR) images with good efficacy, such as segmentation, estimation, and detection of diseases.
arxiv +1 more source
Modeling nonlocal behavior in epidemics via a reaction-diffusion system incorporating population movement along a network [PDF]
, 2022 The outbreak of COVID-19, beginning in 2019 and continuing through the time of writing, has led to renewed interest in the mathematical modeling of infectious disease. Recent works have focused on partial differential equation (PDE) models, particularly reaction-diffusion models, able to describe the progression of an epidemic in both space and time ...
arxiv +1 more source
Immunoglobulin G4-Related Thyroid Disease: A Single-Center Experience and Literature Review [PDF]
Endocrinology and Metabolism, 2022 Background Immunoglobulin G4 (IgG4)-related disease is an entity that can involve the thyroid gland. The spectrum of IgG4-related thyroid disease (IgG4-RTD) includes Hashimoto thyroiditis (HT) and its fibrotic variant, Riedel thyroiditis, as well as ...
Meihua Jin +7 more
doaj +1 more source
Management of patients with Graves' disease and orbital involvement: role of spectral domain optical coherence tomography [PDF]
, 2018 PURPOSE: To investigate the role of choroidal thickness evaluation with spectral domain optical coherence tomography (SDOCT) and enhanced depth imaging (EDI) technique in the management of patients with Graves' disease and orbitopathy (GO).
Bruscolini, A +7 more
core +1 more source
Updates in the Management of Graves Disease in Children
The Ewha Medical Journal, 2023 Graves disease (GD) is the primary cause of hyperthyroidism in children. The standard management options—namely, antithyroid drugs (ATD), radioactive iodine, and surgery—have not changed for many years.
Yun Jeong Lee
doaj +1 more source
Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease [PDF]
Endocrinology and Metabolism, 2022 Background Radioactive iodine (RAI) therapy is a successful therapeutic modality for Graves’ disease. However, RAI therapy can fail, and RAI therapy after antithyroid drugs (ATDs) has a lower remission rate.
Min Joo Kim +6 more
doaj +1 more source
Microchimerism in Graves’ Disease [PDF]
, 2012 Microchimerism is the presence of cells from one individual in another genetically distinct individual. Pregnancy is the main cause of natural microchimerism through transplacental bidirectional cell trafficking between mother and ...
Galofre, J.C. (Juan Carlos)
core +3 more sources
Radioiodine treatment for graves’ disease: a 10-year Australian cohort study
BMC Endocrine Disorders, 2018 Background Radioactive iodine (I131) is a common definitive treatment for Graves’ Disease. Potential complications include worsening, or new development of Graves’ eye disease and development of a radiation thyroiditis.
Erin Fanning +2 more
doaj +1 more source